Hualan Biological Vaccine Inc. (SHE:301207)
China
· Delayed Price · Currency is CNY 19.42
0.00 (0.00%)
Mar 9, 2026, 3:04 PM CST
Hualan Biological Vaccine Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Market Capitalization | 11,555 | 10,418 | 16,680 | 17,832 | - | - | Upgrade
|
| Market Cap Growth | 6.76% | -37.54% | -6.46% | - | - | - | Upgrade
|
| Enterprise Value | 8,479 | 8,180 | 14,346 | 15,905 | - | - | Upgrade
|
| Last Close Price | 19.42 | 16.80 | 25.82 | 27.44 | - | - | Upgrade
|
| PE Ratio | 163.99 | 50.69 | 19.40 | 34.32 | - | - | Upgrade
|
| Forward PE | 10.73 | 9.86 | 15.22 | - | - | - | Upgrade
|
| PS Ratio | 11.83 | 9.24 | 6.92 | 9.77 | - | - | Upgrade
|
| PB Ratio | 2.04 | 1.73 | 2.66 | 3.24 | - | - | Upgrade
|
| P/TBV Ratio | 2.04 | 1.74 | 2.67 | 3.26 | - | - | Upgrade
|
| P/FCF Ratio | 40.97 | 25.02 | 20.21 | 90.98 | - | - | Upgrade
|
| P/OCF Ratio | 38.60 | 22.26 | 18.78 | 61.78 | - | - | Upgrade
|
| EV/Sales Ratio | 8.68 | 7.25 | 5.95 | 8.71 | - | - | Upgrade
|
| EV/EBITDA Ratio | 139.25 | 34.81 | 14.03 | 24.91 | - | - | Upgrade
|
| EV/EBIT Ratio | - | 86.43 | 16.27 | 31.55 | - | - | Upgrade
|
| EV/FCF Ratio | 30.06 | 19.64 | 17.38 | 81.14 | - | - | Upgrade
|
| Debt / Equity Ratio | - | 0.05 | 0.05 | 0.06 | 0.18 | 0.09 | Upgrade
|
| Debt / EBITDA Ratio | - | 1.28 | 0.29 | 0.47 | 0.68 | 0.18 | Upgrade
|
| Debt / FCF Ratio | - | 0.72 | 0.36 | 1.53 | - | 1.24 | Upgrade
|
| Net Debt / Equity Ratio | -0.54 | -0.49 | -0.37 | -0.34 | -0.16 | -0.30 | Upgrade
|
| Net Debt / EBITDA Ratio | -50.51 | -12.45 | -2.26 | -2.90 | -0.61 | -0.61 | Upgrade
|
| Net Debt / FCF Ratio | -10.90 | -7.03 | -2.80 | -9.43 | 6.82 | -4.12 | Upgrade
|
| Asset Turnover | 0.13 | 0.14 | 0.32 | 0.32 | 0.45 | 0.89 | Upgrade
|
| Inventory Turnover | 1.13 | 1.50 | 2.24 | 2.69 | 4.64 | 5.71 | Upgrade
|
| Quick Ratio | 3.02 | 3.19 | 2.73 | 2.57 | 1.43 | 1.65 | Upgrade
|
| Current Ratio | 3.26 | 3.40 | 3.10 | 2.73 | 1.51 | 1.70 | Upgrade
|
| Return on Equity (ROE) | 1.20% | 3.35% | 14.63% | 12.51% | 24.86% | 53.63% | Upgrade
|
| Return on Assets (ROA) | -0.67% | 0.76% | 7.32% | 5.43% | 10.28% | 24.23% | Upgrade
|
| Return on Invested Capital (ROIC) | -2.92% | 2.58% | 19.83% | 14.81% | 30.53% | 73.15% | Upgrade
|
| Return on Capital Employed (ROCE) | -1.40% | 1.60% | 14.00% | 9.10% | 23.60% | 48.10% | Upgrade
|
| Earnings Yield | 0.61% | 1.97% | 5.16% | 2.91% | - | - | Upgrade
|
| FCF Yield | 2.44% | 4.00% | 4.95% | 1.10% | - | - | Upgrade
|
| Dividend Yield | 3.09% | 1.19% | 2.32% | 0.73% | - | - | Upgrade
|
| Payout Ratio | 196.37% | 162.67% | 13.95% | 17.49% | 2.06% | 0.50% | Upgrade
|
| Buyback Yield / Dilution | 1.11% | 0.71% | -2.03% | -9.33% | -0.01% | 0.24% | Upgrade
|
| Total Shareholder Return | 4.20% | 1.91% | 0.29% | -8.61% | -0.01% | 0.24% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.